0001415889-19-000055.txt : 20190115 0001415889-19-000055.hdr.sgml : 20190115 20190115162936 ACCESSION NUMBER: 0001415889-19-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190114 FILED AS OF DATE: 20190115 DATE AS OF CHANGE: 20190115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singh Shawn CENTRAL INDEX KEY: 0001412071 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 19527357 MAIL ADDRESS: STREET 1: C/O VISTAGEN THERAPEUTICS, INC. STREET 2: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-01152019_010122.xml X0306 4 2019-01-14 0001411685 VistaGen Therapeutics, Inc. VTGN 0001412071 Singh Shawn C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2019-01-14 4 M 0 21250 1.50 A 21250 D Common Stock 2019-01-14 4 M 0 1125 1.50 A 22375 D Common Stock 2019-01-14 4 M 0 3000 1.50 A 25375 D Common Stock 26234 I By Trust Stock Option (Right to Buy) 1.50 2019-01-14 4 M 0 21250 0 D 2018-08-29 2019-12-31 Common Stock 21250 0 D Stock Option (Right to Buy) 1.50 2019-01-14 4 M 0 1125 0 D 2018-08-28 2019-06-17 Common Stock 1125 0 D Stock Option (Right to Buy) 1.50 2019-01-14 4 M 0 3000 0 D 2018-08-29 2019-03-24 Common Stock 3000 0 D /s/ Jerrold D. Dotson, Attorney-in-Fact 2019-01-15